128 related articles for article (PubMed ID: 15299190)
1. The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patients.
Jurisić V; Konjević G; Jancić-Nedeljkov R; Sretenović M; Banicević B; Colović M; Spuzić I
Med Oncol; 2004; 21(2):179-85. PubMed ID: 15299190
[TBL] [Abstract][Full Text] [Related]
2. Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas.
Jurisić V; Konjević G; Banićević B; Duricić B; Spuzić I
Eur J Haematol; 2000 Apr; 64(4):259-66. PubMed ID: 10776698
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin's lymphomas.
Jurisic V; Bumbasirevic V; Konjevic G; Djuricic B; Spuzic I
Ann Hematol; 2004 Feb; 83(2):84-91. PubMed ID: 14586559
[TBL] [Abstract][Full Text] [Related]
4. [Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors].
Konjević G; Jurisić V; Jakovljević B; Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):137-47. PubMed ID: 16078448
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum lactate dehydrogenase, β2-microglobulin and vascular endothelial growth factor level detection in patients with non-Hodgkin's lymphoma].
Duan Y; Li G; Hu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):608-10. PubMed ID: 22739165
[TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.
Lu R; Jiang M; Chen Z; Xu X; Hu H; Zhao X; Gao X; Guo L
PLoS One; 2013; 8(9):e74853. PubMed ID: 24086384
[TBL] [Abstract][Full Text] [Related]
7. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
[TBL] [Abstract][Full Text] [Related]
8. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma.
Dumontet C; Drai J; Bienvenu J; Berard EN; Thieblemont C; Bouafia F; Bayle F; Moullet I; Salles G; Coiffier B
Leukemia; 1999 May; 13(5):811-7. PubMed ID: 10374888
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
10. Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma.
Suarez CR; Andreeff M; Miller DR
Med Pediatr Oncol; 1984; 12(2):89-92. PubMed ID: 6583472
[TBL] [Abstract][Full Text] [Related]
11. The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.
Konjević G; Jurisić V; Banićevic B; Spuzić I
Br J Haematol; 1999 Jan; 104(1):144-51. PubMed ID: 10027727
[TBL] [Abstract][Full Text] [Related]
12. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.
Sandlund JT; Murphy SB; Santana VM; Behm F; Jones D; Berard CW; Furman WL; Ribeiro R; Crist WM; Greenwald C; Chen G; Walter A; Pui CH
J Clin Oncol; 2000 Aug; 18(16):3018-24. PubMed ID: 10944136
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.
Hagberg H; Siegbahn A
Scand J Haematol; 1983 Jul; 31(1):49-56. PubMed ID: 6867608
[TBL] [Abstract][Full Text] [Related]
14. Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphoma.
Endrizzi L; Fiorentino MV; Salvagno L; Segati R; Pappagallo GL; Fosser V
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):945-9. PubMed ID: 6891644
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
16. [Expression of the neopterin in serum and urine of the patients with non-Hodgkin's lymphoma].
Cheng XC; Li HC; Zhang R; Tan J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):443-6. PubMed ID: 15972138
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non- Hodgkin's lymphoma].
Chen W; Luo RC; Fan WW; Ma SD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):227-8, 230. PubMed ID: 16503538
[TBL] [Abstract][Full Text] [Related]
18. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
[TBL] [Abstract][Full Text] [Related]
19. The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects.
Jurisic V; Radenkovic S; Konjevic G
Adv Exp Med Biol; 2015; 867():115-24. PubMed ID: 26530363
[TBL] [Abstract][Full Text] [Related]
20. [Non-Hodgkin's lymphomas. I. Clinico-biological features of 307 cases].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Torres M; Valero MI; Ríos MJ; García Julián G; Giralt M
Sangre (Barc); 1992 Oct; 37(5):331-6. PubMed ID: 1293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
